FDA to inspect Chinese-imported seafood

Jun 28, 2007

The U.S. Food and Drug Administration announced an expansion Thursday of its import control of certain Chinese farm-raised seafood.

FDA officials said they begin detaining Chinese imported catfish, bass, shrimp, dace, and eel at the border until the shipments are proven free of residues from drugs not approved for use in U.S. farm-raised aquatic animals.

"We're taking this strong step because of current and continuing evidence that certain Chinese aquaculture products imported into the United States contain illegal substances that are not permitted in seafood sold in the United States," said Dr. David Acheson, the FDA's assistant commissioner for food protection.

Officials said October 2006 through May 2007 sampling repeatedly found farm-raised Chinese seafood was contaminated with antimicrobial agents that are not approved for such use in the United States. The antimicrobials included nitrofuran, malachite green, gentian violet -- all shown to be carcinogenic with long-term exposure in lab animals.

The FDA said it was not seeking recall of any products already in U.S. commerce since the levels of the drug residues have been very low, most often at or near the minimum level of detection.

Copyright 2007 by United Press International

Explore further: Court clears German safety body in breast implant scare

Related Stories

Former federal agent pleads guilty to stealing bitcoins

5 hours ago

A former undercover federal agent pleaded guilty to extortion and related charges after acknowledging he channeled more than $700,000 in digital currency from the Silk Road online drug bazaar he was investigating.

Cities, regions, demand bigger climate say

5 hours ago

Leaders of city and regional governments gathered Wednesday in the French city of Lyon, in the grips of a western European heatwave, to demand a bigger stake in the global push to curb global warming.

Hewlett-Packard moves forward with plan to split in two

5 hours ago

Hewlett-Packard is moving forward with plans to split into two companies, filing paperwork to create a new entity that will sell commercial technology, while a separate spinoff will sell personal computers and printers.

Recommended for you

Drug and device firms paid $6.5B to care providers

Jun 30, 2015

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.